FGF19 and hepatocellular carcinoma: Whereas the diabetic db/db mouse model allows us to simultaneously study anti-diabetic and tumorigenic effects of FGF19, the Mdr2−/− mice, an animal model of chronic liver disease, enables simultaneous interrogation of the hepatoprotective, as well as, HCC-promoting actions of FGF19.